Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR REDI Early Career Transition Award - HIV/AIDS and STBBI

University of British Columbia

$270,000.00

Epigenetic and molecular regulation of aging and age-related comorbidities

FY 2023-24

Summary
Scientific advances in human health have led to longer life expectancy worldwide. In Canada, the aging population (65 years and older) will grow by 68 percent (10.4 million people) in the next 20 years, making healthy aging a nationwide concern. Aging is a risk factor for many conditions and diseases, including Chronic Obstructive Pulmonary Disease (COPD), which is a lung disease characterized by breathing difficulties. Some individuals appear to be at a higher risk of developing age-related conditions, such as COPD, even at a relatively early stage of life, but it is not clear why. For instance, people living with the human immunodeficiency virus (HIV) (PLWH) develop COPD earlier than their uninfected counterparts. My research has shown that the lungs of COPD patients are also characterized by advanced aging. This age acceleration appears to be even worse in PLWH. However, the biology of age acceleration in these populations is not yet fully understood. In the first phase of this project, using a computational approach, I will investigate how epigenetics (modifications to an individual's DNA) contribute to rapid aging in COPD and HIV-associated COPD. I will then develop so-called "aging clocks" to calculate lung age based on specific markers in the lung tissues of healthy people and COPD patients. The findings of Phase 1 will set the foundation for my transition to an independent researcher. In Phase 2, I will continue testing the ability of lung- and COPD-specific clocks to predict clinical outcomes, while also working towards investigating the progression of aging in the general population and in different diseases through genomic integration.
Program
CIHR REDI Early Career Transition Award - HIV/AIDS and STBBI
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
491111
Name
Hernandez Cordero Ana I
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
CIHR REDI Early Career Transition Award
Projecttitle
Epigenetic and molecular regulation of aging and age-related comorbidities
Programtype2
Fellowship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$270,000
Cihrequipment2
$0
Programname2
CIHR REDI Early Career Transition Award - HIV/AIDS and STBBI
Keyworddelim
Aging; Biomakers; Epigentics; Healthy Aging; Hiv; Mechanims
Abstract
Scientific advances in human health have led to longer life expectancy worldwide. In Canada, the aging population (65 years and older) will grow by 68 percent (10.4 million people) in the next 20 years, making healthy aging a nationwide concern. Aging is a risk factor for many conditions and diseases, including Chronic Obstructive Pulmonary Disease (COPD), which is a lung disease characterized by breathing difficulties. Some individuals appear to be at a higher risk of developing age-related conditions, such as COPD, even at a relatively early stage of life, but it is not clear why. For instance, people living with the human immunodeficiency virus (HIV) (PLWH) develop COPD earlier than their uninfected counterparts. My research has shown that the lungs of COPD patients are also characterized by advanced aging. This age acceleration appears to be even worse in PLWH. However, the biology of age acceleration in these populations is not yet fully understood. In the first phase of this project, using a computational approach, I will investigate how epigenetics (modifications to an individual's DNA) contribute to rapid aging in COPD and HIV-associated COPD. I will then develop so-called "aging clocks" to calculate lung age based on specific markers in the lung tissues of healthy people and COPD patients. The findings of Phase 1 will set the foundation for my transition to an independent researcher. In Phase 2, I will continue testing the ability of lung- and COPD-specific clocks to predict clinical outcomes, while also working towards investigating the progression of aging in the general population and in different diseases through genomic integration.
Competitiondate
202305
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Hernandez Cordero, Ana I
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $270,000~ $0~